Kalcifilaksja
Objawy

Kalcifilaksja, zwana także kalcyficzną arteriolopatią mocznicową, to rzadka, ale potencjalnie śmiertelna choroba charakteryzująca się kalcyfikacją małych naczyń krwionośnych, prowadzącą do niedokrwienia i martwicy tkanek. Najczęściej dotyczy pacjentów z końcowym stadium niewydolności nerek poddawanych dializoterapii, choć może wystąpić także u osób bez niewydolności nerek. Klinicznie manifestuje się intensywnym, często palącym bólem, który może poprzedzać widoczne zmiany skórne, takie jak siatkowy rumień (livedo reticularis), bolesne guzki i plamiste przebarwienia o barwie fioletowo-czerwonej lub brunatnej. Progresja choroby prowadzi do powstawania głębokich, niegojących się owrzodzeń pokrytych czarno-brązowym strupem, martwicy skóry i tkanek podskórnych (sucha gangrena), najczęściej lokalizujących się w obszarach bogatych w tkankę tłuszczową (brzuch, uda, pośladki, piersi). Wskaźnik śmiertelności jednorocznej wynosi od 45% do 80%, a u pacjentów z owrzodzeniami przekracza 80% w ciągu 6 miesięcy, głównie z powodu posocznicy wynikającej z zakażenia ran.

Objawy kalcifilaksji

Kalcifilaksja (znana również jako kalcyficzna arteriolopatia mocznicowa) to rzadka, ale potencjalnie śmiertelna choroba, charakteryzująca się kalcyfikacją małych naczyń krwionośnych, co prowadzi do niedokrwienia tkanek i martwicy. Choroba ta najczęściej występuje u pacjentów z końcowym stadium niewydolności nerek poddawanych dializoterapii, choć może również wystąpić u osób bez niewydolności nerek.12

Wczesne objawy kalcifilaksji

Głównym objawem kalcifilaksji jest ból, który często pojawia się przed wystąpieniem widocznych zmian skórnych. Ból ten jest zwykle bardzo intensywny, a obszary dotknięte chorobą mogą stać się nadwrażliwe na dotyk i ucisk, co dodatkowo nasila dolegliwości bólowe.34 Pacjenci często opisują ten ból jako wyjątkowo dotkliwy, palący, a niekiedy towarzyszy mu świąd w miejscach zmian.5

We wczesnym stadium choroby na skórze pojawiają się charakterystyczne zmiany w postaci:67

  • Siatkowego rumienia (livedo reticularis) – fioletowo-czerwone przebarwienia skóry układające się w siateczkowaty wzór
  • Plamistego zabarwienia skóry o kolorze czerwonym, fioletowym lub brązowym
  • Bolesnych guzków lub płytek podskórnych

57

Skóra w tych miejscach może stać się twarda, skórzasta lub tworzyć pęcherze. Zmiany te charakteryzują się wyjątkową bolesnością, nieproporcjonalną do ich rozmiaru.38

Progresja choroby

Z czasem początkowe zmiany skórne ulegają progresji do bardziej zaawansowanych form. W miarę rozwoju choroby, obserwuje się:31

  • Przekształcanie się guzków i plamistych zmian w głębokie, bardzo bolesne owrzodzenia
  • Owrzodzenia pokryte czarno-brązowym strupem, który nie goi się samoistnie
  • Rozszerzanie się ran w charakterystyczny gwiaździsty kształt
  • Nieprzyjemny zapach wydobywający się z ran
  • Odpadanie martwiczych fragmentów skóry

49

W zaawansowanym stadium choroby dochodzi do martwicy skóry i tkanek podskórnych (sucha gangrena), co objawia się czarnymi, skórzastymi strupami (eschary) oraz głębokimi owrzodzeniami, które bardzo rzadko goją się samoistnie.105

Lokalizacja zmian

Zmiany skórne w kalcifilaksji najczęściej występują w obszarach o dużej zawartości tkanki tłuszczowej, takich jak:119

  • Brzuch (powłoki brzuszne)
  • Uda
  • Pośladki
  • Piersi

12

Jednak zmiany mogą pojawić się w dowolnym miejscu ciała, w tym na kończynach dolnych, gdzie kalcifilaksja jest jedną z przyczyn zespołu niebieskiego palca (blue toe syndrome).513 Rzadziej zmiany mogą wystąpić na zewnętrznych narządach płciowych, tułowiu czy kończynach górnych.1415

Warto zaznaczyć, że występowanie zmian w okolicach proksymalnych (brzuch, uda, pośladki) wiąże się z gorszym rokowaniem niż w przypadku zmian dystych (palce, kończyny).1617

Objawy ogólnoustrojowe

Oprócz zmian skórnych, kalcifilaksja może powodować objawy ogólnoustrojowe, takie jak:1819

  • Zmęczenie i osłabienie (choć może to być bardziej objaw dializoterapii niż samej kalcifilaksji)
  • Ogólne złe samopoczucie
  • Bóle i skurcze mięśni

2021

W rzadkich przypadkach, gdy złogi wapnia występują nie tylko pod skórą, ale również w narządach wewnętrznych, mogą pojawić się dodatkowe objawy, takie jak:2223

  • Problemy ze wzrokiem – gdy złogi wapnia dostają się do oczu
  • Krwawienia wewnętrzne
  • Uszkodzenia mięśni

24

Powikłania i przebieg choroby

Najczęstsze powikłania

Kalcifilaksja prowadzi do szeregu poważnych powikłań, które znacząco wpływają na jakość życia pacjentów i ich rokowanie:95

  • Uporczywy, silny ból – jeden z najbardziej charakterystycznych i obciążających objawów kalcifilaksji, prowadzący do znacznego ograniczenia aktywności pacjenta
  • Rozległe, niegojące się owrzodzenia – które nie reagują na standardowe metody leczenia
  • Zakażenia wtórne – niegojące się rany są podatne na infekcje bakteryjne
  • Posocznica (sepsa) – zakażenie może rozprzestrzenić się do krwiobiegu, prowadząc do zagrażającej życiu posocznicy

2526

W rzadszych przypadkach obserwuje się dodatkowe powikłania, takie jak:27

  • Złamania patologiczne (np. szyjki kości udowej) z powodu osłabienia kości
  • Powstawanie przetok (np. przetoki odbytniczo-pochwowej)
  • Niewydolność narządowa

2728

Przebieg choroby i rokowanie

Kalcifilaksja jest chorobą przewlekłą i obecnie nieuleczalną, choć w niektórych przypadkach możliwe jest osiągnięcie remisji po leczeniu.22 Jednak nawet przy odpowiednim leczeniu, rokowanie dla pacjentów z kalcifilaksją jest zwykle niepomyślne.29

Wskaźniki śmiertelności w kalcifilaksji są alarmująco wysokie:2010

  • Śmiertelność jednoroczna wynosi od 45% do 80%
  • W przypadku pacjentów z owrzodzeniami śmiertelność może przekraczać 80% w ciągu 6 miesięcy
  • Tylko około 20% pacjentów z zaawansowanymi zmianami przeżywa ponad 6 miesięcy

223031

Główną przyczyną zgonu u pacjentów z kalcifilaksją jest posocznica (sepsa) wynikająca z zakażenia niegojących się ran.2532 Innymi przyczynami zgonu mogą być niewydolność wielonarządowa lub powikłania sercowo-naczyniowe.28

Czynniki wpływające na rokowanie w kalcifilaksji obejmują:3334

  • Czas rozpoznania – wcześniejsze rozpoznanie wiąże się z lepszym rokowaniem
  • Lokalizacja zmian – zmiany proksymalne (brzuch, uda) mają gorsze rokowanie niż dystalne
  • Stadium zaawansowania – obecność głębokich owrzodzeń znacząco pogarsza rokowanie
  • Typ kalcifilaksji – pacjenci z kalcifilaksją niemocznicową (niezwiązaną z niewydolnością nerek) mają lepsze rokowanie
  • Szybkość wdrożenia leczenia – wczesne rozpoczęcie kompleksowego leczenia może poprawić rokowanie

303116

Problemy z zarządzaniem bólem

Ból stanowi jeden z najbardziej charakterystycznych i najtrudniejszych do opanowania objawów kalcifilaksji.35 Pacjenci doświadczają mieszanego bólu nocyceptywnego i neuropatycznego, który jest wyjątkowo intensywny i często oporny na standardowe metody leczenia.36

Charakterystyka bólu w kalcifilaksji:3738

  • Niezwykle intensywny, nieproporcjonalny do wielkości zmian skórnych
  • Może poprzedzać pojawienie się widocznych zmian skórnych
  • Często towarzyszy mu nadwrażliwość na dotyk (hiperalgezja)
  • Może mieć charakter palący, kłujący lub piekący
  • Wymaga stosowania silnych leków przeciwbólowych, w tym opioidów

3536

Leczenie bólu w kalcifilaksji jest szczególnie trudne u pacjentów z końcowym stadium niewydolności nerek, którzy są bardziej narażeni na działania toksyczne opioidów z powodu różnic w metabolizmie i wydalaniu leków.35 Dlatego zaleca się wieloczynnikowe podejście do kontroli bólu, które może obejmować:39

  • Stosowanie opioidów dostosowanych do funkcji nerek
  • Leki przeciwpadaczkowe (gabapentyna, pregabalina)
  • Blokady nerwów
  • Benzodiazepiny
  • Ketamina

3639

Ból związany z kalcifilaksją prowadzi do znacznego obniżenia jakości życia pacjentów, ograniczenia ich aktywności fizycznej i funkcjonowania społecznego, często wymuszając leżący tryb życia lub konieczność korzystania z wózka inwalidzkiego.4035

Progresja zmian skórnych

Zmiany skórne w kalcifilaksji przechodzą charakterystyczne stadia rozwoju, od wczesnych objawów do zaawansowanych zmian martwiczych.41 Znajomość tej progresji jest kluczowa dla wczesnego rozpoznania i wdrożenia leczenia.21

Stadia progresji zmian skórnych

  1. Stadium początkowe:
    • Bolesne obszary skóry bez widocznych zmian
    • Siatkowe przebarwienia (livedo reticularis)
    • Rumień lub plamiste zmiany o zabarwieniu fioletowo-czerwonym
  2. Stadium tworzenia się guzków i płytek:
    • Bolesne, wyczuwalne guzki podskórne
    • Płytki skórne o charakterystycznym fioletowym lub brunatnym zabarwieniu
    • Skóra staje się twarda, skórzasta
    • Może dochodzić do tworzenia się pęcherzy wypełnionych krwią
  3. Stadium owrzodzenia:
    • Pęcherze pękają, tworząc bolesne owrzodzenia
    • Owrzodzenia pokryte czarno-brązowym strupem
    • Rany rozszerzają się w charakterystyczny gwiaździsty kształt
    • Pojawia się nieprzyjemny zapach
  4. Stadium martwicy:
    • Rozległe obszary martwicy (sucha gangrena)
    • Czarne, skórzaste strupy (eschary)
    • Odpadanie martwiczych fragmentów skóry
    • Wysokie ryzyko zakażenia i posocznicy

106742

Progresja zmian może przebiegać bardzo szybko, w ciągu kilku dni lub tygodni, prowadząc do rozległych owrzodzeń i martwicy.543 Owrzodzenia rzadko goją się samoistnie i wymagają specjalistycznego leczenia.44

Czynniki wpływające na progresję zmian

Na szybkość i charakter progresji zmian skórnych w kalcifilaksji wpływają różne czynniki:4045

  • Zaburzenia gospodarki wapniowo-fosforanowej – wysoki iloczyn wapniowo-fosforanowy (>70) przyspiesza progresję zmian
  • Nadczynność przytarczyc – wysokie poziomy parathormonu nasilają kalcyfikację naczyń
  • Stosowanie warfaryny – może przyspieszać rozwój zmian skórnych
  • Stosowanie kortykosteroidów – może nasilać kalcyfikację naczyń
  • Otyłość – zwiększa ryzyko i nasilenie zmian w obszarach o dużej zawartości tkanki tłuszczowej
  • Urazy – mogą inicjować lub przyspieszać rozwój zmian w miejscu uszkodzenia

4639

Badania wskazują, że intensywne zarządzanie zaburzeniami metabolizmu wapniowo-fosforanowego może prowadzić do regresji owrzodzeń w niektórych przypadkach.45 Nowe badania sugerują również, że blokowanie szlaku interleukiny-6 (IL-6) może zapobiegać progresji owrzodzeń skórnych i łagodzić ból u pacjentów z kalcifilaksją.4748

Nietypowe manifestacje kalcifilaksji

Choć kalcifilaksja najczęściej objawia się zmianami skórnymi, w rzadkich przypadkach może prowadzić do nietypowych manifestacji klinicznych, które stanowią dodatkowe wyzwanie diagnostyczne i terapeutyczne.4927

Kalcifilaksja narządowa

W niektórych przypadkach kalcyfikacja może dotyczyć naczyń w narządach wewnętrznych, prowadząc do:5051

  • Kalcyfikacji płucnej – objawiającej się dusznością, kaszlem i niewydolnością oddechową
  • Kalcyfikacji sercowej – mogącej prowadzić do ostrego bloku serca i nagłej śmierci sercowej
  • Kalcyfikacji mięśni szkieletowych – powodującej osłabienie mięśni i ból
  • Kalcyfikacji narządów brzusznych – żołądka lub nerek, prowadzącej do włóknienia i zakrzepicy

51

Kalcifilaksja narządów płciowych

Rzadką, ale poważną manifestacją kalcifilaksji jest zajęcie zewnętrznych narządów płciowych, szczególnie prącia.5253 Kalcifilaksja prącia objawia się:

  • Bolesnym, sinym lub ciemnym przebarwieniem żołędzi
  • Rozwojem owrzodzeń i martwicy
  • W skrajnych przypadkach autoamputacją końcówki prącia

5253

Kalcifilaksja prącia jest stanem zagrażającym życiu, z szacowaną śmiertelnością 6-miesięczną wynoszącą około 50%.53

Powikłania kostne

W rzadkich przypadkach kalcifilaksja może wiązać się z patologicznymi złamaniami kości, szczególnie szyjki kości udowej, co obserwowano w niektórych opisach przypadków.27 Pacjenci mogą zgłaszać nagły, ostry ból w okolicy biodra w spoczynku, a badania radiologiczne mogą wykazać złamanie szyjki kości udowej i ścieńczenie kości korowej.27

Powikłania w układzie pokarmowym

Opisywano również rzadkie przypadki powikłań w obrębie układu pokarmowego, takie jak:27

  • Owrzodzenia w okolicy pachwin
  • Owrzodzenia pochwy
  • Przetoki odbytniczo-pochwowe

27

Te nietypowe manifestacje kalcifilaksji podkreślają, że choroba ta może wpływać na różne układy i narządy, nie ograniczając się tylko do zmian skórnych. Świadomość możliwości występowania tych rzadkich objawów jest istotna dla kompleksowej opieki nad pacjentami z kalcifilaksją.2751

Diagnostyka kalcifilaksji

Wczesne rozpoznanie kalcifilaksji ma kluczowe znaczenie dla poprawy rokowania pacjentów.33 Diagnostyka tej choroby opiera się na ocenie klinicznej, badaniach laboratoryjnych i histopatologicznych.50

Obraz kliniczny

Rozpoznanie kalcifilaksji często opiera się na charakterystycznym obrazie klinicznym:643

  • Bolesne zmiany skórne o charakterze siatkowym, plamistym lub guzkowym
  • Progresja do owrzodzeń z czarnym strupem (escharem)
  • Wyjątkowo silny ból, nieproporcjonalny do rozmiaru zmian
  • Typowa lokalizacja zmian w obszarach bogatych w tkankę tłuszczową

7

W zaawansowanych stadiach rozpoznanie kliniczne jest zazwyczaj bardziej oczywiste. Dobrze odgraniczone, martwicze, stwardniałe zmiany skórne, które są obustronne, u pacjenta z końcowym stadium niewydolności nerek bez objawów wstrząsu, czynią rozpoznanie kalcifilaksji bardzo prawdopodobnym.6

Badania laboratoryjne

W badaniach laboratoryjnych u pacjentów z kalcifilaksją często stwierdza się:720

  • Podwyższony iloczyn wapniowo-fosforanowy (>70)
  • Hiperkalcemia i hiperfosfatemia
  • Podwyższony poziom parathormonu (PTH)
  • Podwyższony poziom mocznika i kreatyniny
  • Podwyższony OB (wskaźnik opadania erytrocytów)

46

Liczba białych krwinek powyżej 15 000 komórek/mm³ jest związana z gorszym rokowaniem.46 Należy jednak pamiętać, że nieprawidłowe wyniki badań laboratoryjnych nie są specyficzne dla kalcifilaksji i mogą występować również w innych chorobach.54

Badania obrazowe

Badania obrazowe mogą być pomocne w diagnostyce kalcifilaksji:54

  • Radiografia konwencjonalna – może uwidocznić charakterystyczne rozgałęzione zwapnienia naczyń w obrębie skóry i tkanki podskórnej
  • Scyntygrafia kości – może wykazać zwiększone wychwyty w obszarach kalcyfikacji i być przydatna do monitorowania progresji lub regresji choroby

54

Biopsja skóry

Biopsja skóry z badaniem histopatologicznym pozostaje najlepszą metodą potwierdzenia rozpoznania kalcifilaksji.50 Typowe zmiany histopatologiczne obejmują:2755

  • Zwapnienia w błonie środkowej małych tętniczek skóry i tkanki podskórnej
  • Znaczne zwężenie światła naczyń z pogrubieniem błony wewnętrznej (proliferacja fibrointymalna)
  • Zakrzepy w pozostałym świetle naczyń
  • Nacieki zapalne
  • Martwica tłuszczowa

5455

Próbka do biopsji powinna być pobrana z brzegu zmiany, aby uniknąć tkanki martwiczej, która może utrudnić rozpoznanie, ale nie powinna być pobrana zbyt daleko od brzegu, gdyż może to prowadzić do wyników fałszywie ujemnych.55

Należy jednak zauważyć, że biopsja skóry niesie ze sobą ryzyko niegojących się ran i infekcji, dlatego decyzja o jej wykonaniu powinna być podejmowana indywidualnie, po rozważeniu potencjalnych korzyści i ryzyka.56

Podsumowanie objawów i progresji kalcifilaksji

Kalcifilaksja jest rzadką, ale potencjalnie śmiertelną chorobą, charakteryzującą się kalcyfikacją małych naczyń krwionośnych, prowadzącą do niedokrwienia tkanek i martwicy.1 Choroba ta najczęściej występuje u pacjentów z końcowym stadium niewydolności nerek poddawanych dializoterapii, choć może również wystąpić u osób bez niewydolności nerek.2

Główne objawy kalcifilaksji obejmują:911

  • Intensywny ból, często występujący przed pojawieniem się widocznych zmian skórnych
  • Siatkowe, fioletowo-czerwone przebarwienia skóry (livedo reticularis)
  • Bolesne guzki i płytki podskórne
  • Owrzodzenia pokryte czarno-brązowym strupem, które nie goją się samoistnie
  • Zakażenia ran, które mogą prowadzić do posocznicy (sepsy)

28

Zmiany skórne najczęściej występują w obszarach o dużej zawartości tkanki tłuszczowej, takich jak brzuch, uda, pośladki i piersi, ale mogą pojawić się w dowolnym miejscu ciała.9

Progresja kalcifilaksji jest zwykle szybka i niekorzystna, z jednoroczną śmiertelnością wynoszącą od 45% do 80%.10 Główną przyczyną zgonu jest posocznica wynikająca z zakażenia niegojących się ran.32

Wczesne rozpoznanie i leczenie ma kluczowe znaczenie dla poprawy rokowania pacjentów z kalcifilaksją.31 Leczenie jest wielokierunkowe i obejmuje zarządzanie zaburzeniami gospodarki wapniowo-fosforanowej, leczenie ran, kontrolę bólu oraz zapobieganie i leczenie zakażeń.45

Kalcifilaksja pozostaje poważnym wyzwaniem medycznym, wymagającym multidyscyplinarnego podejścia i dalszych badań nad skutecznymi metodami leczenia tej niszczącej choroby.5748

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Calciphylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK519020/
    Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare but potentially devastating condition most often observed in patients with end-stage renal disease, although it does occasionally develop in patients without renal failure. It is characterized by cutaneous arteriolar calcification and subsequent tissue ischemia and infarction and causes painful skin lesions. Calciphylaxis is associated with substantial morbidity due to severe pain, non-healing wounds, and frequent hospitalizations. It is a highly fatal condition with 1-year mortality rates greater than 50 percent, most frequently due to sepsis. […] Calciphylaxis typically presents with extremely painful ischemic cutaneous lesions or painful subcutaneous nodules without skin changes, although at times, pain may precede the development of the lesions. Skin lesions often appear as violaceous or erythematous subcutaneous nodules and plaques. Livedo reticularis can also result from ischemia. As the lesions progress, they may become ulcerated with the development of necrosis, eschar, and infection. Proximal areas with increased adipose tissue such as the abdomen, thighs, and buttocks are most commonly involved, although distal sites such as the digits can also be affected. Extreme pain is a hallmark of calciphylaxis leading to considerable morbidity.
  • #2 Calciphylaxis (calcific uremic arteriolopathy) – UpToDate
    https://www.uptodate.com/contents/calciphylaxis-calcific-uremic-arteriolopathy
    Calciphylaxis is a rare and serious disorder that presents with skin ischemia and necrosis and is characterized histologically by calcification of arterioles and capillaries in the dermis and subcutaneous adipose tissue. It is a lethal disease that carries a high morbidity and mortality, with an estimated six-month survival of approximately 50 percent. […] Calciphylaxis most commonly occurs in patients who have end-stage kidney disease (ESKD) and are on dialysis but may also occur in kidney transplant recipients and in non-ESKD patients. […] This topic reviews the pathogenesis, diagnosis, and treatment of calciphylaxis in ESKD (calcific uremic arteriolopathy) and non-ESKD patients.
  • #3 Calciphylaxis: Symptoms & Causes
    https://my.clevelandclinic.org/health/diseases/22359-calciphylaxis
    Calciphylaxis can look different depending on its severity. […] Symptoms of calciphylaxis may include: Pain. Most cases of calciphylaxis are very painful. The sensation of pain may start before lesions or any other visible signs appear. The affected areas can also become hypersensitive to pressure or touch, making the pain more intense. […] Lesions (earlier stages). These are areas of skin that turn red, purple, brown or black. These lesions usually have a netlike appearance. They may also blister, and the affected area of skin may become hardened and leathery. […] Ulcers and wounds (later stages). Lesions usually become wounds that spread outward in starlike shapes. The wounds often have a foul smell. Areas of dead skin and flesh may turn black and take on a scab-like appearance and fall off.
  • #4 Calciphylaxis: What Causes it and Is it Fatal?
    https://www.webmd.com/skin-problems-and-treatments/what-is-calciphylaxis
    Calciphylaxis can be characterized by large, purple, web-like markings on the skin. Another common sign is the appearance of large, brown, crusted sores. […] Symptoms of calciphylaxis are distinctive. Most patients suffering from this disease will show these symptoms: […] Extreme pain. Patients may complain about pain in their skin before there are any visible signs of calciphylaxis. This is one of the first symptoms most people will experience. […] Purple or red skin markings. These markings will usually form a web or net-like pattern on the skin and be very painful. In the earlier stages, they will be purple or red. Later, they may change to brown or black. The texture of the skin can also change by becoming hard and leathery or blistered. […] Sores that dont heal. The blister sites will turn into lesions on the skin. These sores develop black or brown crusts that are extremely painful. They will usually start to develop a star-shaped pattern and putrid smell. Crusted parts of the lesions tend to fall off, but the wound will continue to grow.
  • #5 Calciphylaxis: Causes, Symptoms, and Management — DermNet
    https://dermnetnz.org/topics/calciphylaxis
    Calciphylaxis begins as surface purple-coloured mottling of the skin (retiform purpura) then bleeding occurs within the affected area. There may be blood-filled blisters. The skin goes black in the centre of star-shaped (stellate) purple lesions. The skin cells die because of lack of blood supply (dry gangrene). This causes deep and often extensive ulcers. Surgical intervention may aggravate ulceration. […] Patients with calciphylaxis usually experience severe pain, burning and sometimes itching at the lesion sites. […] Calciphylaxis most often occurs on the lower limb where it is one of the causes of blue toe syndrome. Lesions on the fatty areas of the trunk, abdomen, buttocks, or thighs appear to be more dangerous than lesions on the lower legs and feet. […] Calciphylaxis can lead to: Chronic and extensive ulceration, Secondary infection with sepsis, Death.
  • #6 Advanced-stage calciphylaxis: Think before you punch | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/83/8/562
    A 53-year-old woman presented with extensive, nonulcerated, painful plaques on both calves. […] The patient presented with extensive necrotic, leathery, violaceous lesions on both calves that resembled eschar. […] In the early stages, lesions of calciphylaxis are focal and appear as erythema or livedo reticularis with or without subcutaneous plaques or ulcers. As the disease progresses, the ischemic changes coalesce to form denser violaceous, painful, plaquelike subcutaneous nodules with eschar. In the advanced stages, the eschar or ulceration involves an extensive area. […] In the advanced stages, the diagnosis of calciphylaxis is clinically more evident, and the differential diagnosis usually narrows. Well-demarcated, necrotic, indurated lesions that are bilateral in a patient with end-stage renal disease without shock makes the diagnosis very likely.
  • #7 Calciphylaxis (Calcific uremic arteriolopathy) – Dermatology Advisor
    https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/calciphylaxis-calcific-uremic-arteriolopathy/
    Clinically the lesions of calciphylaxis are heterogeneous; however patients often first report dysesthesia in a small area of erythema or livedo reticularis prior to the rapid eruption of multiple tender, violaceous nodules or plaques. […] These lesions progress to central necrosis or a painful eschar surrounded by angulate or stellate ulcerations, rarely preceded by hemorrhagic flaccid bullae. […] Patients may also demonstrate palpable subcutaneous calcified nodules and plaques associated with surrounding pruritus. […] Lesions are usually symmetric, bilateral, and well-demarcated, typically overlying thick adipose tissue or areas of trauma. […] Complications include secondary wound infection and gangrene. […] The leading cause of death is sepsis. […] Patients with calciphylaxis may have a calcium-phosphate product higher than 70, in addition to elevated levels of urea, parathyroid hormone, and/or ESR.
  • #8
    https://www.kidney.org.uk/calciphylaxis-information
    Calciphylaxis causes ulcers (skin sores). This commonly occur around the abdomen and legs but can affect any area of the body including (but not limited to) the torso, breast and external genitalia. The main symptom (from the ulcers) is pain which can be extreme and may seem disproportionate (worse than you would expect) for the ulcer size.
  • #9 Mayo Clinic Health Library – Calciphylaxis | Swiss Medical Network
    https://www.swissmedical.net/fr/healtcare-library/con-20370550
    Calciphylaxis symptoms include blood clots, lumps under the skin and painful open sores called ulcers. If an ulcer becomes infected, it can be life-threatening. […] Calciphylaxis symptoms include: Large netlike patterns on the skin that may look purple-pink in color. Deep, painful lumps in the skin that can become ulcers. The ulcers often have a black-brown crust that doesn’t heal on its own. Ulcers tend to appear in areas with high fat content, such as the stomach, thighs, buttocks and breasts. But they can form anywhere. Infections from ulcers that don’t heal. […] Complications of calciphylaxis include: Serious pain. Large, deep ulcers that do not heal on their own. Blood infections. Death, mainly due to infection or organ failure.
  • #10 Calciphylaxis – Wikipedia
    https://en.wikipedia.org/wiki/Calciphylaxis
    Calciphylaxis is characterized by painful skin lesions. […] The first skin changes in calciphylaxis lesions are mottling of the skin and induration in a livedo reticularis pattern. As tissue thrombosis and infarction occurs, a black, leathery eschar in an ulcer with adherent black slough develops. […] These lesions are always extremely painful and most often occur on the lower extremities, abdomen, buttocks, and penis. […] Because the tissue has infarcted, wound healing seldom occurs, and ulcers are more likely to become secondarily infected. Many cases of calciphylaxis lead to systemic bacterial infection and death. […] Overall, the clinical prognosis for calciphylaxis is poor. The 1-year mortality rate in patients who have end-stage kidney disease is 45-80%. […] Median survival in patients who do not have end-stage kidney disease is 4.2 months. […] The most common cause of death in calciphylaxis patients is sepsis, severe infection originating from a non-healing ulcer.
  • #11 Calciphylaxis – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/calciphylaxis/symptoms-causes/syc-20370559
    Calciphylaxis symptoms include blood clots, lumps under the skin and painful open sores called ulcers. If an ulcer becomes infected, it can be life-threatening. […] Calciphylaxis symptoms include: […] Deep, painful lumps in the skin that can become ulcers. The ulcers often have a black-brown crust that doesn’t heal on its own. Ulcers tend to appear in areas with high fat content, such as the stomach, thighs, buttocks and breasts. But they can form anywhere. […] Infections from ulcers that don’t heal.
  • #12 Calciphylaxis Diagnosis and Management in Primary Care
    https://www.clinicaladvisor.com/features/calciphylaxis-diagnosis-treatment-primary-care/
    Clinical findings include purple or red net-like areas of ecchymoses that are painful or nonhealing ulcers that are painful. […] The time frame between dialysis initiation to calciphylaxis diagnosis was 4 years and between calciphylaxis diagnosis to death was 6 months. […] One-year mortality rates are greater than 50%. […] The most common site of calciphylaxis injury is the lower extremities followed by the breasts and abdomen. […] Calciphylaxis is a relatively rare condition characterized by ischemic skin lesions resulting from calcium deposits occluding microvessels creating painful areas of ecchymoses that lead to dark-colored lesions and eventually necrosis.
  • #13 Calciphylaxis: Causes and Outlook
    https://resources.healthgrades.com/right-care/vascular-conditions/calciphylaxis
    Calciphylaxis occurs when skin cells die due to a lack of blood supply. Symptoms include blisters, bleeding, and pain. […] Calciphylaxis causes painful, blood-filled lesions to form on the skin. It mainly affects people with end-stage kidney disease. […] Many cases of the condition can have fatal consequences. Other cases lead to nonhealing wounds and frequent hospitalizations. […] Calciphylaxis is a potentially fatal condition with a 1-year mortality rate of over 50%. This means more than half of all people with the condition may die within a year. […] Calciphylaxis lesions usually have the following features: Location: Calciphylaxis patches most commonly form on the lower limbs. However, they can also appear on the trunk, abdomen, buttocks, or thighs. Color: Calciphylaxis often begins as a purple-colored patch or blotch. It also typically causes the skin to become dark. Blistering: The patches typically turn into blood-filled blisters and then ulcers over time. Distribution: The ulcers can grow deep into the skin and become extensive. Pain: Extreme pain is common with calciphylaxis. Other sensations: Severe burning and itching may also occur at the sites of the lesions. Syndrome: Calciphylaxis can cause blue-toe syndrome, which causes muscle pain in the legs and severe pain in the foot.
  • #14
    https://www.kidney.org.uk/calciphylaxis-information
    Calciphylaxis is a serious condition that can occur in people chronic with kidney disease; it is most commonly seen in people receiving dialysis but remains very rare with approximately one case diagnosed in every 600 people, having dialysis, per year. […] Calciphylaxis commonly affects the soft tissues of the body around the abdomen and legs but can affect any area of the body including (but not limited to) the torso, breast and external genitalia. The main symptom (from the ulcers) is pain which can be extreme. If the ulcers become infected then this can result in hospital admission. People can feel weak and unwell; this may be caused by a combination of factors including the pain, possibly infection, along with the burden of undergoing the treatments. Whilst some people make a good recovery, sadly around 5 out of 10 people die within a year of diagnosis.
  • #15 Calciphylaxis in chronic renal failure: An approach to risk factors – Indian Journal of Nephrology
    https://indianjnephrol.org/calciphylaxis-in-chronic-renal-failure-an-approach-to-risk-factors/
    We present a case of calcifying panniculitis due to calciphylaxis in a nontherapy compliance 65-year-old man suffering from chronic renal failure. Calciphylaxis, a life threatening condition, is characterized by high calcium phosphate product, presence of calcium crystals in the skin and secondary hyperparathyroidism. The clinical presentation includes painful firm plaques, which could progress to nonhealing ulcers. […] The clinical presentation includes primary lesions as painful firm plaques or subcutaneous nodules which progress to secondary lesions as non-healing ulcers. […] This process can result in tissue necrosis, gangrene and sepsis. […] The lesion manifests itself characteristically in lower extremities particularly the thighs and buttocks, but less frequently in abdomen, upper extremities and penis.
  • #16 Calciphylaxis: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1095481-overview
    Calciphylaxis (also referred to as calcific uremic arteriolopathy) is a poorly understood and highly morbid syndrome of vascular calcification and skin necrosis. […] The pathogenesis of calciphylaxis remains obscure and is likely the result of a multiplicity of comorbid factors or events. […] The clinical appearance of the lesions of calciphylaxis (livedo reticularis and stellate purpura) suggests that the common endpoint of the process is small-vessel occlusion. Indeed, microthrombi are found in most cases. […] The prognosis is generally not good, with mortality as high as 60-80% having been reported in patients with ulcerative disease. […] Mortality is higher in patients with proximal disease than in those with only distal or acral disease.
  • #17 Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal | Nefrología
    https://www.revistanefrologia.com/en-calciphylaxis-in-patients-with-chronic-articulo-resumen-S2013251418301068
    Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare syndrome that typically causes skin necrosis and usually affects dialysis patients. […] From a clinical point of view, calciphylaxis may progress from painful purpura to extensive areas of skin necrosis that can potentially lead to superinfection and the death of the patient due to sepsis. […] It is usually manifested in two phases; first, cutaneous erythema and pruritus and the second with very painful ulceration and skin necrosis. The latter is associated with a high mortality rate. […] The distribution of the lesions may be proximal (areas with more adipose tissue) or distal which is the most frequent and with a better prognosis. […] Mortality is between 30% and 80% depending on the comorbidities and the configuration of cutaneous involvement. In recent years, mortality seems to have improved, especially since the pathology is better known, action is taken more quickly and some treatment alternatives are available.
  • #18 Calciphylaxis: treatment, symptoms, causes and diagnosis
    https://www.kidneyresearchuk.org/conditions-symptoms/calciphylaxis/
    Calciphylaxis symptoms include very painful skin sores, which may begin as purple or red in appearance (before becoming black) and most commonly occur around the abdomen and legs but can affect any area of the body. […] The skin ulcers put people at high risk of developing infections which can lead to hospital admission. […] People with calciphylaxis can feel tired, weak, and unwell due to pain (which can be severe), possibly infection and from side effects of treatments. […] Whilst some people make a good recovery, sadly around 5 in 10 people with the condition will die within a year of diagnosis.
  • #19 SSA – POMS: DI 23022.128 – Calciphylaxis – 08/09/2023
    https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022128
    Calciphylaxis is a rare metabolic disease in which calcium builds up in the walls of veins and arteries, blocking blood flow and resulting in damage to multiple organ systems. The denial of blood to tissues causes painful, infected sores on the skin that cannot heal without external intervention. […] Physical signs and symptoms of calciphylaxis may include: Fatigue; Pain; Muscle weakness; Aches and cramps; Vision problems; Skin lesions and sores; and Skin necrosis. […] The prognosis for people with calciphylaxis is extremely poor. The condition tends to advance rapidly, causing intense pain and organ failure. The disease is usually fatal.
  • #20 Calciphylaxis: Pictures, Definition, Symptoms, Treatment, and Outlook
    https://www.healthline.com/health/calciphylaxis
    The main symptom of calciphylaxis includes skin lesions on the lower limbs or areas with higher fat content, such as the breasts, buttocks, and abdomen. […] The lesions eventually progress to extremely painful ulcers or nodules, which are difficult to heal. […] A person with calciphylaxis may have higher levels of calcium (hypercalcemia) and phosphate (hyperphosphatemia) in the blood. […] Symptoms like fatigue and weakness, however, may be symptoms of dialysis rather than calciphylaxis. […] Calciphylaxis is a highly fatal condition. The 1-year survival rate is less than 50%. Death is usually a result of complications, such as infections and sepsis. […] Successful management of calciphylaxis symptoms is possible, and early diagnosis and treatment can lead to better outcomes even without a cure. The survival rate is expected to improve as more research is performed. […] Common symptoms include painful skin lesions or ulcers.
  • #21 Calciphylaxis | Kidney Care UK
    https://kidneycareuk.org/kidney-disease-information/kidney-conditions/calciphylaxis/
    Calciphylaxis can make people feel very tired and unwell, although this may be more of a symptom of dialysis rather than the condition itself. […] Calciphylaxis causes ulcers to develop on the skin. These usually occur on the legs and abdomen but can affect any part of the body. The ulcers can be extremely painful and can become infected. […] Although calciphylaxis occurs as a result of kidney damage, it mostly affects the skin, causing extremely painful ulcers that can become infected. […] Half of all people with calciphylaxis die within a year of diagnosis. Death usually occurs because of infection from the ulcers.
  • #22 Calciphylaxis: Symptoms & Causes
    https://my.clevelandclinic.org/health/diseases/22359-calciphylaxis
    Vision problems, internal bleeding and muscle damage. Other problems are possible in rare cases where calcium deposits happen internally and not just beneath your skin. […] Calciphylaxis is a chronic, lifelong condition because it currently isnt curable. But its possible, in some cases, for the disease to go into remission after treatment. Researchers dont know how long its possible to keep it in remission. […] About half of all people with calciphylaxis dont survive more than a year, with sepsis being the most common cause of death. […] The later a diagnosis happens, the worse the prognosis tends to be. About 20% of people survive more than six months if theyve developed wounds or ulcers.
  • #23 Calciphylaxis: What Causes it and Is it Fatal?
    https://www.webmd.com/skin-problems-and-treatments/what-is-calciphylaxis
    Vision problems. In some cases, these calcium deposits can make their way into the eyes and impair your vision. […] Internal organ damage. Calciphylaxis can affect your major internal organs. It can cause internal bleeding and tissue damage. […] Approximately half of the people who get calciphylaxis die within a year of diagnosis. The chances of survival depend strongly on what stage the disease is in when its diagnosed. […] Another factor affecting survival rates is whether the calciphylaxis is uremic or non-uremic. Non-uremic patients tend to have a higher rate of survival.
  • #24 Calciphylaxis – Inozyme
    https://www.inozyme.com/patients-and-families/calciphylaxis/
    Calciphylaxis, also known as calcific uremic arteriopathy, is a rare disease with a high mortality rate that mostly affects people with end-stage kidney disease (ESKD). It is characterized by painful sores and wounds that are hard to heal. […] Initial skin lesions typically present as extremely painful plaques and nodules, and progress to severe ulcers and tissue death. Approximately 50% of calciphylaxis patients die within a year of diagnosis. […] Hydroxyapatite crystal deposits form in blood vessels and block blood flow, leading to sores where skin and tissue break down and die. […] Deep, painful lumps ulcerate and create open sores that fail to heal. These ulcers often occur on the skin of the abdomen and thighs but can appear anywhere on the body. […] Serious infections occur due to wounds on the skin that spread and do not heal, which can lead to major complications including sepsis (blood infection), the most common cause of death in people with calciphylaxis.
  • #25 Calciphylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK519020/
    Calciphylaxis has a poor prognosis with 1-year mortality rates between 45% and 80%, and the response to therapy is also poor. Patients with ulcerated lesions are particularly prone to developing an infection, which is the leading cause of death. […] Superimposed infections of the affected regions are the most common complication of this disease. Due to the often underlying immunocompromised status of the patients, the risk of associated sepsis is high as well. Less severe, though equally devastating complication of this disease is debility due to pain. Calciphylaxis lesions are extremely painful and result in significant morbidity for the patients.
  • #26 Calciphylaxis – MD Searchlight
    https://mdsearchlight.com/health/calciphylaxis/
    The main complication of this disease is additional infections in the impacted areas. Patients with this disease often have weakened immune systems, which greatly increases the risk of sepsis, a life-threatening infection that can spread throughout the body. […] A less severe but still extremely troublesome issue associated with this disease is debilitating pain. Lesions caused by this disease, known as calciphylaxis, are extremely painful and can greatly reduce a patient’s quality of life.
  • #27 Calciphylaxis Presenting with Various Symptoms: A Case Report
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5346948/
    Skin biopsy of the periphery of the ulcers showed calcification of the intima media of the small arteries in the dermis, and extensive inflammatory cell infiltration was observed in the periphery. Therefore, she was diagnosed with calciphylaxis. […] One month after hospitalization, she complained of acute pain in the left hip during rest. A radiograph revealed fracture of the left femoral neck and thinning of the cortical bone. […] In the second month after onset, new ulcers formed in the right groin and vagina. […] The vaginal ulcer formed a rectovaginal fistula within several days. […] This patient was diagnosed with calciphylaxis based on ulcers on both thighs, which was followed by complications of femoral neck fracture, groin ulcers, and a rectovaginal fistula. The patient ultimately died of cardiac failure. […] Calciphylaxis causes refractory ulcers and various complications throughout the body.
  • #28 Calciphylaxis | Beacon Health System
    https://www.beaconhealthsystem.org/library/diseases-and-conditions/calciphylaxis?content_id=CON-20370550
    Calciphylaxis symptoms include blood clots, lumps under the skin and painful open sores called ulcers. If an ulcer becomes infected, it can be life-threatening. […] Calciphylaxis symptoms include: Large netlike patterns on the skin that may look purple-pink in color. Deep, painful lumps in the skin that can become ulcers. The ulcers often have a black-brown crust that doesn’t heal on its own. Ulcers tend to appear in areas with high fat content, such as the stomach, thighs, buttocks and breasts. But they can form anywhere. Infections from ulcers that don’t heal. […] Complications of calciphylaxis include: Serious pain. Large, deep ulcers that do not heal on their own. Blood infections. Death, mainly due to infection or organ failure. […] Often, the outlook for people with calciphylaxis isn’t hopeful. Finding and treating any infections early is key to preventing serious complications.
  • #29 Calciphylaxis // Middlesex Health
    https://middlesexhealth.org/learning-center/diseases-and-conditions/calciphylaxis
    Signs and symptoms of calciphylaxis include: […] Deep, very painful lumps that ulcerate creating open sores with black-brown crust that fails to heal typically in skin areas with high fat content, such as the stomach and thigh, although they can occur anywhere […] Infections from wounds that don’t heal. […] Complications of calciphylaxis include: […] Large, deep, nonhealing ulcers. […] Typically, the outlook for people with calciphylaxis isn’t hopeful. Early detection and treatment is very important in helping to prevent serious infections.
  • #30 Calciphylaxis: Causes, Symptoms, and Management — DermNet
    https://dermnetnz.org/topics/calciphylaxis
    Mortality in patients with calciphylaxis associated with chronic renal disease is reported to be 6080%. Death is usually from secondary infection of the ulcers, and sepsis. […] Death is less likely when warfarin is the cause of calciphylaxis, with 15 of 18 patients reported to have fully recovered.
  • #31 Calciphylaxis in chronic renal failure: An approach to risk factors – Indian Journal of Nephrology
    https://indianjnephrol.org/calciphylaxis-in-chronic-renal-failure-an-approach-to-risk-factors/
    Calciphylaxis (or calcific uremic arteriolopathy) is a serious life-threatening condition characterized by progressive calcium salt deposition in small and medium sized vessel and superficial soft tissue. […] Though after application of several measures, the clinical presentation of our patient was significantly improved, the long-term prognosis in such patient remains poor. Fine et al. demonstrated a mortality rate of 33% at six months in patient who presented only plaques which increased to above 80% in those patients developing ulceration. […] It is important for the clinician to be aware of this entity, because prompt diagnosis and treatment may halt progression of disease and minimize mortality rate.
  • #32 Calciphylaxis: Causes and Outlook
    https://resources.healthgrades.com/right-care/vascular-conditions/calciphylaxis
    Calciphylaxis skin lesions typically start as discolored patches. Over time, they blister and turn into open sores. They also cause the tissue surrounding the wound to die. […] Sepsis is the main cause of death in people with calciphylaxis. […] People with calciphylaxis can develop blood infections and sepsis. They may also experience extensive ulcers and chronic pain. […] Calciphylaxis has a 1-year mortality rate of over 50%. Death usually results from secondary infections and sepsis. […] Calciphylaxis causes painful, blood-filled lesions to form on the skin. It results when calcium deposits accumulate within the blood vessels. Symptoms include blisters, bleeding, and pain.
  • #33 Stages of Calciphylaxis Progression – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Group
    https://www.acibademhealthpoint.com/stages-of-calciphylaxis-progression/
    Recognizing the symptoms of calciphylaxis is the first step towards seeking medical intervention. Early diagnosis and timely treatment can significantly improve the outcomes for individuals affected by this condition. […] Understanding the prognosis and long-term outlook for individuals with calciphylaxis is crucial in ensuring appropriate management and care. Various factors influence the prognosis of calciphylaxis patients, including the extent of tissue necrosis, the presence of underlying comorbidities, and the timely initiation of treatment. […] Studies indicate that the overall prognosis for calciphylaxis is poor, with high mortality rates. The condition is associated with significant morbidity and complications, making early diagnosis and intervention essential. Without timely and appropriate treatment, calciphylaxis can progress rapidly and lead to severe tissue necrosis, non-healing wounds, infection, and potentially fatal outcomes.
  • #34 What is the exam of calciphylaxis? | Stanford Medicine 25 | Stanford Medicine
    https://stanfordmedicine25.stanford.edu/blog/archive/2016/can-you-diagnose-this-rare-skin-condition.html
    Unfortunately, even with appropriate treatment, calciphylaxis remains extremely deadly. The estimated 1-year survival rate in one study was 45.8%; more than half of deaths are caused by infection. Although some patients treated with a multi-modality approach as described above can see improvement and even disappearance of lesions, they nevertheless suffer from high morbidity due to pain, immobility and frequent medical interventions. Overall prognosis seems to be better if calciphylactic lesions are treated early in their development, stressing the importance of recognizing this rare condition and prompt treatment of any associated skin and soft tissue infections.
  • #35 CALCIPHYLAXIS, A CASE SERIES – PAIN & SYMPTOM MANAGEMENT RECOMMENDATIONS AND ROLE OF RENAL SUPPORTIVE CARE
    https://anzsnevents.com/12828/
    Calciphylaxis is a rare condition caused by calcification of microvessels in the dermis and subcutaneous tissue, leading to development of severe painful skin lesions which progress to areas of necrosis and ulceration over time. […] Pain was a common distressing symptom and was refractory to usual analgesia. These patients had severe mixed nociceptive and neuropathic pain, requiring a combination of various analgesia modalities for management including an opioid and gabapentinoid. […] Pain contributed to significant morbidity, reduced poor quality of life and poor functional status. […] Pain management can be challenging in patients with ESKD, who are at higher risk of opioid toxicity due to differences in drug metabolism and excretion.
  • #36 Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations | Published in Orthopedic Reviews
    https://orthopedicreviews.openmedicalpublishing.org/article/37573-perioperative-management-of-calciphylaxis-literature-review-and-treatment-recommendations
    Calciphylaxis is a serious and rare medical condition that leads to substantial clinical manifestations including pain, creating perioperative and treatment challenges. […] This calcification leads to clinically significant manifestations such as painful ischemic sores, often with associated tactile hyperesthesia. […] A particularly debilitating feature of this disease is pain. The pain associated with ischemic calciphylaxis lesions is described as excruciating and unrelenting and often leads to a decline in patients functional status and to repeated hospitalizations. […] Poor wound healing and difficult pain control are common. […] Therefore, a multifactorial approach to controlling postoperative pain is recommended that includes the use of nerve blocks, renal-sparing opioids, benzodiazepines, and/or ketamine.
  • #37 Reddit – The heart of the internet
    https://www.reddit.com/r/kidneydisease/comments/igrd5q/calciphylaxis/
    A relative of mine has been diagnosed with calciphylaxis. The disease involves calcium build ups that result in intense pain and ulcers that do not heal. […] The pain is extreme and really hard to alleviate as it is total body pain coupled with open debrided wounds on the back and hips.
  • #38 P-41 Calciphylaxis and palliative care. Complex symptoms, treatment side effects and choosing the optimal model of supportive care. A case study and discussion | BMJ Supportive & Palliative Care
    https://spcare.bmj.com/content/14/Suppl_3/A50.1
    Calciphylaxis, or calcific uraemic arteriolopathy (CUA), is a clinical syndrome usually associated with advanced renal disease, which is characterized by vascular calcification and the development of painful ischaemic ulcers. […] Calciphylaxis also causes significant symptom burden, with painful skin lesions requiring a specialised approach to analgaesia. […] Ischaemic wound pain in calciphylaxis is well described, and our patient required multiple analgaesic agents to achieve adequate pain relief. However, her most burdensome symptom was severe nausea and vomiting, which related to sodium thiosulfate infusions one of few recognized treatments for the disease. […] Our case highlights the role of specialist palliative care working in novel ways, alongside nephrologists in providing optimal symptom management to manage the complex symptom burden associated with calciphylaxis and its treatments.
  • #39 Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations | Published in Orthopedic Reviews
    https://orthopedicreviews.openmedicalpublishing.org/article/37573-perioperative-management-of-calciphylaxis-literature-review-and-treatment-recommendations
    The resultant clinical effects of calciphylaxis create perioperative treatment challenges. Skin ulcerations can predispose to infection with the potential for spread to deeper sites, and death from sepsis is a common finding in calciphylaxis vasculopathy. […] Surgical debridement of necrotic ulcers is often necessary to preserve surrounding tissue, and patients may require repeated surgical procedures after diagnosis and near the end of life. […] Calciphylaxis may be triggered or exacerbated by corticosteroids and blood transfusions. […] Poor wound healing is another postsurgical issue. […] Adequate pain control is notoriously difficult to achieve for patients with calciphylaxis, requiring a multifactorial approach.
  • #40 Rapid regression of calciphylaxis in a hemodialysis patient after intensive management of disturbance of calcium and phosphate metabolism: a case report with literature review | Renal Replacement Therapy | Full Text
    https://rrtjournal.biomedcentral.com/articles/10.1186/s41100-019-0216-9
    Calciphylaxis, a multifactorial cutaneous vascular disease, is a rare but therapy-resistant and life-threatening disorder that usually occurs in patients with end-stage kidney disease (ESKD). […] Clinically, calciphylaxis is characterized by chronic, painful, and non-healing wounds. […] Approximately 50% of patients with calciphylaxis are bedridden or wheelchair-bound, and more than 70% require hospitalization because of severe ulcers. […] The pathophysiology of calciphylaxis is complex, and it is believed to have several causative factors. […] Calciphylaxis is also known by the alias calcific uremic arteriolopathy, since the accumulation of uremic toxins is believed to be involved in the pathogenesis of this condition. […] Generally, appropriate management of Ca-P metabolism is recognized to be important in the treatment of calciphylaxis.
  • #41 Stages of Calciphylaxis Progression – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Group
    https://www.acibademhealthpoint.com/stages-of-calciphylaxis-progression/
    Stages of Calciphylaxis Progression As calciphylaxis progresses, it goes through distinct stages, each with its own set of symptoms and potential complications. By recognizing these stages, individuals and healthcare providers can take proactive steps to prevent further deterioration and seek timely treatment. […] Calciphylaxis is a rare but serious condition characterized by the development of skin lesions, pain, and tissue necrosis. Early recognition of these symptoms is crucial to prevent further complications and facilitate prompt medical intervention. By understanding the common signs and symptoms of calciphylaxis, individuals at risk or experiencing these symptoms can seek appropriate care. […] Common symptoms of calciphylaxis include painful skin lesions, skin discoloration, non-healing wounds, and necrosis. Some individuals may also experience fever, malaise, and weight loss. It is important to recognize these symptoms early and seek medical attention to prevent further complications.
  • #42 FF #325 Uremic Calciphylaxis | Palliative Care Network of Wisconsin
    https://www.mypcnow.org/fast-fact/uremic-calciphylaxis/
    Calciphylaxis is a poorly understood disorder in which calcification of small blood vessels causes painful ischemic skin and visceral lesions most often in patients with end-stage renal disease (ESRD). […] Calciphylaxis occurs in 4% of ESRD patients on peritoneal dialysis or hemodialysis and can occasionally occur in pre-dialysis renal disease. […] Over time this process likely precipitates arteriolar remodeling and progressive stenosis, causing ischemia and skin infarcts. […] The one-year mortality rate for calciphylaxis is estimated to be 45-80%, which may be even higher when ulcerative skin lesions are present. […] Early signs include pain and a lace-like purplish discoloration of the skin (livedo reticularis). This is often followed by painful subcutaneous nodules or plaques that progress to necrotic ulcerations. […] Areas of greatest fat tissue — abdomen, buttocks, and inner thighs — are most commonly involved, although visceral organs, skeletal muscle, and heart muscle can also be affected. […] Calciphylaxis can be challenging to distinguish from a vasculitis.
  • #43 Calciphylaxis Diagnosis and Management in Primary Care
    https://www.clinicaladvisor.com/features/calciphylaxis-diagnosis-treatment-primary-care/
    A 54-year-old man presents to a hospice inpatient unit for pain management and wound care. The patients medical history includes end-stage renal disease (ESRD), calciphylaxis, and type 2 diabetes. Review of his medical history reveals that the patient initially presented 6 months prior with superficial reddening of the skin. […] The reddening rapidly progressed into nonhealing ulcers and the patient underwent above the knee amputation. […] Skin changes associated with calciphylaxis have sudden onset and progress rapidly to open ulcerations and then necrosis. […] A painful necrotic ulcer covered with black eschar that started as painful ecchymoses is usually the presenting symptom; patients often mistake initial reddening for a bruise and delay seeking medical care. […] The presence of malodorous, dusky, and/or necrotic lesions should increase suspicion of calciphylaxis.
  • #44 What is the exam of calciphylaxis? | Stanford Medicine 25 | Stanford Medicine
    https://stanfordmedicine25.stanford.edu/blog/archive/2016/can-you-diagnose-this-rare-skin-condition.html
    A 49 year-old obese man with non-alcoholic steatohepatitis and cirrhosis, complicated by hepatorenal syndrome not on dialysis, was admitted for expedited liver transplant workup. On admission, he was found to have the lower extremity skin lesions shown below. He noted that these slowly-enlarging lesions had developed over the past 2 months and were extremely tender, requiring opiates to control the pain. […] The lesions of calciphylaxis normally involve tissue with high adiposity, such as the buttocks, thighs and lower abdomen. Localized livedo reticularis may the first sign on exam. Lesions progress from subcutaneous plaques to open ulcerations, necrotic ulcers, and ultimately eschars with a high-risk for secondary bacterial infection. The condition is usually limited to the skin and subcutaneous soft tissues, although occasionally patients can have deeper muscle involvement with frank weakness on exam. The skin lesions themselves are extremely painful and do not heal on their own.
  • #45 Rapid regression of calciphylaxis in a hemodialysis patient after intensive management of disturbance of calcium and phosphate metabolism: a case report with literature review | Renal Replacement Therapy | Full Text
    https://rrtjournal.biomedcentral.com/articles/10.1186/s41100-019-0216-9
    In the present case, appropriate management of Ca-P metabolism led to regression of the ulcers. […] With this therapy, her painful and severe skin ulcers dramatically regressed in only 3 months. […] Therefore, we suggest that intensive management of Ca-P metabolism is essential to prevent the development of calciphylaxis. Hypercalcemia or hyperphosphatemia due to excess VDRA therapy could be an aggravating factor for calciphylaxis in CKD patients on HD.
  • #46 Calciphylaxis (Calcific uremic arteriolopathy) – Dermatology Advisor
    https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/calciphylaxis-calcific-uremic-arteriolopathy/
    White blood cell count levels higher than 15,000 cells/mm3 have been associated with a worse prognosis. […] The mean age is 48 years (ranging from 6 months to 83 years). […] A higher incidence has been suggested in women and Caucasian individuals. […] Other risk factors include hyperparathyroidism, end-stage renal disease of any etiology, elevated calcium-phosphate product, and vitamin D exposure. […] Additionally, obesity, diabetes, liver disease, immunosuppression, lymphoma, blood transfusions, serum aluminum, hypoalbuminemia, calcitriol, HIV, systemic corticosteroids, and local trauma may trigger calciphylaxis in patients who are already predisposed. […] Mortality ranges between 60-87%. […] Calciphylaxis is a heterogeneous disorder with a seemingly multifactorial etiology, and therefore response to treatment is variable.
  • #47 Blocking IL6 Pathway May Prevent Progression of Skin Ulcers in Calciphylaxis CKD-Related Disease
    https://www.pharmacytimes.com/view/blocking-il6-pathway-may-prevent-progression-of-skin-ulcers-in-calciphylaxis-ckd-related-disease
    The IL6 pathway is central to skin lesion development in calciphylaxis, a CKD-related condition, and blocking it may prevent ulcers and pain. […] Calciphylaxis is marked by painful skin ulcers and is common in end-stage kidney disease, with no current cure. […] The findings showed that the IL-6-tissue factor (TF)-inducing ability of calciphylaxis serum was an activity marker and IL-6 as a therapeutic target for uremic calciphylaxis. […] This study reveals the presence of a pathological and harmful cycle between the fat under the skin, sweat glands, and small blood vessels that keep feeding onto itself. If this cycle isn’t stopped and remains unchecked, it will lead to the skin ulcers that won’t heal. […] Those drugs are likely to prevent progression of the skin ulcers and resolve the pain that we see in patients with calciphylaxis.
  • #48 Researchers Identify Pathway Responsible for Calciphylaxis, a Rare and Serious Condition | Chobanian & Avedisian School of Medicine
    https://www.bumc.bu.edu/camed/2025/04/23/researchers-identify-pathway-responsible-for-calciphylaxis-a-rare-and-serious-condition/
    Calciphylaxis typically affects patients with end-stage, advanced kidney disease. It is a condition characterized by severe, painful and non-healing skin ulcers with no known cure. […] Blocking this pathway they believe, will likely prevent progression of the skin ulcers and resolve the pain seen in patients with calciphylaxis. […] If this cycle isnt stopped and remains unchecked, it will lead to the skin ulcers that wont heal. […] Those drugs are likely to prevent progression of the skin ulcers and resolve the pain that we see in patients with calciphylaxis.
  • #49 Calciphylaxis Presenting with Various Symptoms: A Case Report
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5346948/
    Calciphylaxis causes ischemia in multiple organs and skin ulcers owing to progressive calcification in small and medial arteries. […] Here, we present a case of calciphylaxis associated with a wide range of symptoms, including lower thigh skin ulcers, a rectovaginal fistula, and femoral neck fracture. […] The patient started hemodialysis in 2005 for chronic renal failure, and she experienced symptoms associated with hyperparathyroidism complications in 2013. […] She visited our department for an initial examination in June 2015, with the chief complaint of intense pain and purpura in both lower thighs. […] Subsequently, the purpura spots rapidly formed ulcers, and she was hospitalized urgently. […] Clearly demarcated ulcers with yellow gangrenous tissue were observed on her right ankle and several areas of her left leg.
  • #50
    https://link.springer.com/article/10.1007/s12325-020-01504-w
    Cutaneous calciphylaxis refers to the skins lesions that are seen in the disease process, but vascular calcifications and associated complications can present in other organs, such as the skeletal muscle, lungs, eyes, and the brain. […] Pain in cutaneous calciphylaxis (CP) can be severe and debilitating; proper treatment requires a multi-specialty approach. […] The progression of these plaques to an ulcerated state dramatically increases the mortality rate associated with the disease (from 33% to above 80% at 6 months upon development of ulceration). […] Cutaneous lesions manifest in a significant number of patients, such as nodules, plaques, purpura, and ulcers. […] These cutaneous lesions have the potential to be extremely painful and difficult to treat. […] Currently, skin biopsy with histological examination is the best method of diagnosing the disease, with medical imaging being helpful in select cases. […] Treatment of pain must be multimodal and should target the underlying disease etiology, as pain is often associated with the primary disease burden. […] Currently, there are multiple clinical trials in progress in order to provide relief to patients with this debilitating disease.
  • #51 Orphanet: Calciphylaxis
    https://www.orpha.net/en/disease/detail/280062
    A rare vascular calcification disorder typically characterized by occlusion of microvessels in the cutaneous tissue resulting in painful cutaneous lesions. The disorder is often life-limiting. […] Calciphylaxis typically affects patients with end-stage kidney disease (ESKD) treated with dialysis. […] The average age at the time of diagnosis is reported between 50 to 70 years; very few patients are children. Patients with calciphylaxis typically present with painful skin lesions. The pain is typically severe and there is associated tactile hyperesthesia. The initial manifestations may include skin induration, plaques, nodules, livedo, or purpura. The initial lesions rapidly progress to stellate ulcers with black eschars. Sepsis originating from the resultant wounds is considered the most common cause of death. Rarely, diffuse precipitation of calcium in viscera occurs (mainly in the heart or lungs, but also in the stomach or kidneys) which may lead to fibrosis and thrombosis, and eventually tissue necrosis. Depending on the affected organ, patients may present with dyspnea, cough and respiratory failure or acute heart block and subsequent sudden cardiac death. More than 70% of patients with calciphylaxis require hospitalization for severe ulcers. […] Quality of life of patients with calciphylaxis is extremely poor. Once calciphylaxis develops then the patients suffer from substantial morbidity related to pain, wounds and limited mobility, and many die within the first year of disease onset.
  • #52 Penile Calciphylaxis: A Case Report and Review of the Literature – SHM Abstracts | Society of Hospital Medicine
    https://shmabstracts.mystagingwebsite.com/abstract/penile-calciphylaxis-a-case-report-and-review-of-the-literature/
    A 45yearold man with diabetes mellitus and hypertension presented with acute renal failure and multiple lesions on his penis and lower extremities. His lesions worsened despite initiation of hemodialysis and sodium thiosulfate. He developed autoamputation of the tip of his penis. Calciphylaxis is a rare disorder with significant morbidity and mortality. It affects up to 4% of patients with endstage renal disease. The lesions are characterized as systemic medial calcification of the arterioles leading to ischemia and necrosis in increased areas with adipose tissue. An elevated calcium phosphate level (55) or parathyroid hormone level can cause calciphylaxis with variability. Parathyroidectomy can decrease the disease progression. Mortality rate is 50% in the first year and overall is 80%. […] Hospitalists care for many patients with endstage renal disease and need to be cognizant of calciphylaxis given its significant morbidity and mortality. Diagnostic evaluation and special care with skin integrity and treatments should be initiated immediately.
  • #53 Penile Calciphylaxis | Published in Journal of Brown Hospital Medicine
    https://bhm.scholasticahq.com/article/37712-penile-calciphylaxis
    A 65-year-old man with a medical history significant for chronic kidney disease (CKD) and currently on hemodialysis (HD), hyperlipidemia, heart failure with reduced ejection fraction presented to the emergency department with complaints of penile pain for the previous 2 weeks. Initially, the patient noticed a bump in the area around the glans penis and gradually progressed to the extent that the entire area was red, black, and extremely tender. […] Examination of the penis revealed a violaceous, painful, ischemic lesion over the glans. […] Painful cutaneous lesions are the primary presentation of this condition. […] Ultimately these lesions become non-healing ulcers. […] Although rare, penile calciphylaxis is well-described with close to 50 cases reported and less than half of these presenting with isolated penile calciphylaxis. […] Calciphylaxis has an estimated six-month mortality of 50 percent and must be promptly recognized by clinicians.
  • #54 Calciphylaxis Workup: Laboratory Studies, Imaging Studies, Procedures
    https://emedicine.medscape.com/article/1095481-workup
    Calciphylaxis may manifest as rapidly progressive, diffuse and extensive, cutaneous necrosis, as is seen in this patient with chronic renal failure. Bullae may also be seen as a rare manifestation of calciphylaxis. […] Plain radiography uniformly demonstrates an arborization of vascular calcification within the dermis and the subcutaneous tissue. […] A mixed inflammatory infiltrate frequently occurs. Subcutaneous calcium deposits with panniculitis and fat necrosis may sometimes be found. Vascular microthrombi are frequently evident. […] Serial bone scanning may also be useful for monitoring progression or regression of disease.
  • #55 Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal | Nefrología
    https://www.revistanefrologia.com/en-calciphylaxis-in-patients-with-chronic-articulo-resumen-S2013251418301068
    The skin biopsy would confirm the diagnosis of calciphylaxis. The tissue sample should be obtained from the edges of the lesion to avoid necrotic tissue, as this may spoil the diagnosis, but it cannot be taken too far away from the edge because in this case it may result in false negatives. […] The classic anatomopathological findings are defined by the calcification of the tunica media of arterioles from the cutaneous or subcutaneous fat tissue, associated with an important fibro-intimal thickening that decreases the lumen of the vessel which is associated to thrombosis of residual lumen in some vessels.
  • #56 Case Report: Warfarin-Induced Non-Uremic Calciphylaxis Mimicking Vasculitis – The Rheumatologist
    https://www.the-rheumatologist.org/article/case-report-warfarin-induced-non-uremic-calciphylaxis-mimicking-vasculitis/
    Calciphylaxis, or calcific uremic arteriolopathy, is a rare disease characterized by calcification of the arterioles and capillaries in the dermis and subcutaneous tissue, resulting in thrombus formation and subsequent skin ischemia and necrosis. […] Calciphylaxis often presents as cutaneous lesions of livedo reticularis, plaques, nodules and ulcers due to ischemia of the microvasculature. […] Plaques or nodules are the most common presenting lesions, which may be confused with cellulitis because both lesions can present with erythema, pallor and tenderness. […] Patients may have advanced disease, however, once the diagnosis is officially made.
  • #57
    https://link.springer.com/article/10.1007/s12325-020-01504-w
    Calciphylaxis is a deadly, painful disease with a 1-year mortality of up to 50%. […] The progressive arterial calcification seen in calciphylaxis can affect multiple body organs, including the skin, brain, lungs, and muscle. […] In cutaneous calciphylaxis, painful and non-healing nodules, plaques, and ulcers may appear, increasing morbidity for patients. […] Calciphylaxis is a progressive inflammatory disease in which small- and medium-sized arteries are calcified, leading to thrombotic ischemia and multiple dermatologic manifestations, ranging from small nodules and plaques to necrotic ulceration. […] Calciphylaxis is a deadly disease, with the mortality at 6 months being 30% and the mortality at 12 months being 50%. […] In addition to a high mortality, the disease is highly morbid, with many patients experiencing recurrent hospitalizations, severe pain, and non-healing wounds.